✦ LIBER ✦

Risk of Development of the Metabolic Syndrome After Orthotopic Liver Transplantation

✍ Scribed by M.L. Ruiz-Rebollo; G. Sánchez-Antolín; F. García-Pajares; P. Fernández-Orcajo; M. González-Sagrado; M.A. Cítores-Pascual; R. Velicia-Llames; A. Caro-Patón

Book ID: 116936022
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 102 KB
Volume: 42
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2010.02.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolism of cyclosporine after orthoto

Metabolism of cyclosporine after orthotopic liver transplantation

✍ Jean Michel Fabre; Rozangela Pedrosa; Andrée Bonardet; Lydiane Pichard; Bernard 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 828 KB

Metabolic syndrome and its association w

Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation

✍ Sprinzl, Martin F.; Weinmann, Arndt; Lohse, Nikola; Tönissen, Hanna; Koch, Sandr 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 142 KB

Cardiovascular risk factors and the meta

Cardiovascular risk factors and the metabolic syndrome after liver transplantation

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Polyamine metabolism in the rat liver af

Polyamine metabolism in the rat liver after orthotopic liver transplantation

✍ Masanobu Terakura; Ikko Higaki; Isao Matsui-Yuasa; Hiroaki Kinoshita; Shuzo Otan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 779 KB

Cumulative risk of cardiovascular events

Cumulative risk of cardiovascular events after orthotopic liver transplantation

✍ Mazen Albeldawi; Ashish Aggarwal; Surabhi Madhwal; Jacek Cywinski; Rocio Lopez; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

Cumulative risk of cardiovascular events

Cumulative risk of cardiovascular events after orthotopic liver transplantation

✍ Mazen Albeldawi; Ashish Aggarwal; Surabhi Madhwal; Jacek Cywinski; Rocio Lopez; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

As survival after orthotopic liver transplantation (OLT) improves, cardiovascular (CV) disease has emerged as the leading cause of non-graft-related deaths. The aims of our study were to determine the cumulative risk of CV events after OLT and to analyze predictive risk factors for those experiencin